- Conditions: Probable Migraine; Migraine With Aura; Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine; Drug: Metoclopramide
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified May 2012 - Condition: Heterotaxy Syndrome
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Psoriasis
Interventions: Drug: ustekinumab; Drug: placebo
Sponsors: Centocor Research & Development, Inc.; Centocor Research & Development, Inc.
Completed - verified April 2012 - Condition: Metastatic Pancreas Cancer
Interventions: Drug: 5FU, leucovorin, oxaliplatin; Drug: Gemcitabine
Sponsors: Alberta Health Services; Alberta Health Services
Not yet recruiting - verified April 2012 - Condition: Influenza
Intervention:
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Hepatitis C
Intervention: Drug: Boceprevir
Sponsors: University of Calgary; University of Calgary; Merck
Not yet recruiting - verified April 2012

Clinical Trial Locations 